It is widely recognized that insulin resistance is a crucial metabolic dysfunction commonly linked to type 2 DM, referring to the impaired ability of peripheral target tissues, including adipose tissue, to effectively respond to insulin. This evidence concerns the gene INS and Insulin resistance.